Your browser doesn't support javascript.
loading
Vaccine implementation factors affecting maternal tetanus immunization in low- and middle-income countries: Results of the Maternal Immunization and Antenatal Care Situational Analysis (MIACSA) project.
Giles, M L; Mantel, C; Muñoz, F M; Moran, A; Roos, N; Yusuf, N; Diaz, T; Ahun, M; Nic Lochlainn, L M; Wootton, E; Pathirana, J; Rendell, S; Tuncalp, O; Perut, M; Hombach, J; Merten, S; Lambach, P.
Affiliation
  • Giles ML; Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia. Electronic address: michelle.giles@monash.edu.
  • Mantel C; MMGH Consulting, Zurich, Switzerland.
  • Muñoz FM; Departments of Pediatrics, Section of Infectious Diseases, and Molecular Virology and Microbiology, Baylor College of Medicine, Houston TX, USA.
  • Moran A; Department of Maternal, Newborn, Child, Adolescent Health and Ageing, Geneva, Switzerland.
  • Roos N; Department of Maternal, Newborn, Child, Adolescent Health and Ageing, Geneva, Switzerland.
  • Yusuf N; Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
  • Diaz T; Department of Maternal, Newborn, Child, Adolescent Health and Ageing, Geneva, Switzerland.
  • Ahun M; Independent Consultant, McKing Consulting, Geneva, Switzerland.
  • Nic Lochlainn LM; Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
  • Wootton E; Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
  • Pathirana J; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/ National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Rendell S; Department of Anthropology University of Pennsylvania, Philadelphia, USA.
  • Tuncalp O; Department of Sexual and Reproductive Health and Research including UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, WHO, Geneva, Switzerland.
  • Perut M; Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
  • Hombach J; Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
  • Merten S; Swiss Tropical and Public Health Institute and University of Basel, Basel, Switzerland.
  • Lambach P; Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneva, Switzerland.
Vaccine ; 38(33): 5268-5277, 2020 07 14.
Article de En | MEDLINE | ID: mdl-32586763
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tétanos / Pays en voie de développement Type d'étude: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspects: Determinantes_sociais_saude Limites: Child / Female / Humans / Newborn / Pregnancy Langue: En Journal: Vaccine Année: 2020 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tétanos / Pays en voie de développement Type d'étude: Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Aspects: Determinantes_sociais_saude Limites: Child / Female / Humans / Newborn / Pregnancy Langue: En Journal: Vaccine Année: 2020 Type de document: Article